COX7C
gene geneOn this page
Summary
COX7C (cytochrome c oxidase subunit 7C, HGNC:2292) is a protein-coding gene on chromosome 5q14.3, encoding Cytochrome c oxidase subunit 7C, mitochondrial (P15954). Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. It is a selective cancer dependency (DepMap: 81.8% of cell lines).
Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes subunit VIIc, which shares 87% and 85% amino acid sequence identity with mouse and bovine COX VIIc, respectively, and is found in all tissues. A pseudogene COX7CP1 has been found on chromosome 13.
Source: NCBI Gene 1350 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 17 total
- Cancer dependency (DepMap): dependent in 81.8% of screened cell lines
- MANE Select transcript:
NM_001867
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2292 |
| Approved symbol | COX7C |
| Name | cytochrome c oxidase subunit 7C |
| Location | 5q14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000127184 |
| Ensembl biotype | protein_coding |
| OMIM | 603774 |
| Entrez | 1350 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 10 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000247655, ENST00000505430, ENST00000509578, ENST00000510447, ENST00000511472, ENST00000513124, ENST00000515763, ENST00000900830, ENST00000900831, ENST00000927184, ENST00000927185, ENST00000927186, ENST00000927187, ENST00000927188
RefSeq mRNA: 1 — MANE Select: NM_001867
NM_001867
CCDS: CCDS4063
Canonical transcript exons
ENST00000247655 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000998734 | 86617941 | 86618130 |
| ENSE00000998735 | 86620668 | 86620962 |
| ENSE00003492291 | 86619353 | 86619496 |
Expression profiles
Bgee: expression breadth ubiquitous, 296 present calls, max score 99.82.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 351.2982 / max 4860.3445, expressed in 1827 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 57439 | 318.1383 | 1827 |
| 57440 | 11.8908 | 1753 |
| 57441 | 10.6691 | 1675 |
| 57442 | 8.2334 | 1596 |
| 203616 | 2.3666 | 1210 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| heart right ventricle | UBERON:0002080 | 99.82 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.82 | gold quality |
| cardiac atrium | UBERON:0002081 | 99.80 | gold quality |
| cardiac ventricle | UBERON:0002082 | 99.80 | gold quality |
| heart left ventricle | UBERON:0002084 | 99.80 | gold quality |
| apex of heart | UBERON:0002098 | 99.79 | gold quality |
| heart | UBERON:0000948 | 99.77 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 99.77 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 99.73 | gold quality |
| prefrontal cortex | UBERON:0000451 | 99.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 99.72 | gold quality |
| biceps brachii | UBERON:0001507 | 99.71 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 99.70 | gold quality |
| cortical plate | UBERON:0005343 | 99.70 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 99.70 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.70 | gold quality |
| caudate nucleus | UBERON:0001873 | 99.69 | gold quality |
| cingulate cortex | UBERON:0003027 | 99.69 | gold quality |
| muscle of leg | UBERON:0001383 | 99.68 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.68 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.68 | gold quality |
| metanephros cortex | UBERON:0010533 | 99.68 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 99.68 | gold quality |
| gastrocnemius | UBERON:0001388 | 99.67 | gold quality |
| adenohypophysis | UBERON:0002196 | 99.67 | gold quality |
| myocardium | UBERON:0002349 | 99.67 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 99.67 | gold quality |
| pituitary gland | UBERON:0000007 | 99.66 | gold quality |
| muscle organ | UBERON:0001630 | 99.66 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 99.66 | gold quality |
Single-cell (SCXA)
Detected in 14 experiment(s), a significant marker in 7.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9388 | yes | 3731.78 |
| E-CURD-98 | yes | 2464.62 |
| E-MTAB-9221 | yes | 48.35 |
| E-MTAB-7316 | yes | 24.40 |
| E-MTAB-10042 | yes | 15.31 |
| E-HCAD-9 | yes | 8.10 |
| E-HCAD-10 | no | 2429.77 |
| E-MTAB-10596 | no | 2335.45 |
| E-MTAB-10662 | no | 2310.36 |
| E-GEOD-86618 | no | 395.11 |
| E-HCAD-4 | no | 83.52 |
| E-MTAB-8410 | no | 45.85 |
| E-MTAB-8271 | no | 9.50 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): BAP1, HCFC1, RNF2, YY1
miRNA regulators (miRDB)
6 targeting COX7C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-1843 | 98.97 | 66.07 | 838 |
| HSA-MIR-4802-5P | 98.97 | 66.26 | 833 |
| HSA-MIR-640 | 98.44 | 66.93 | 644 |
| HSA-MIR-11401 | 90.58 | 63.72 | 128 |
| HSA-MIR-598-3P | 89.25 | 67.61 | 112 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 81.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- The expression level of COX7C associates with venous thromboembolism in colon cancer patients. (PMID:32653968)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | cox7c | ENSDARG00000104537 |
| mus_musculus | Cox7c | ENSMUSG00000017778 |
| rattus_norvegicus | ENSRNOG00000063840 | |
| rattus_norvegicus | Cox7cl1 | ENSRNOG00000065320 |
| rattus_norvegicus | ENSRNOG00000066702 | |
| drosophila_melanogaster | COX7C | FBGN0040773 |
| caenorhabditis_elegans | cox-7C | WBGENE00009161 |
Protein
Protein identifiers
Cytochrome c oxidase subunit 7C, mitochondrial — P15954 (reviewed: P15954)
Alternative names: Cytochrome c oxidase polypeptide VIIc
All UniProt accessions (2): P15954, D6R9Z7
UniProt curated annotations — full annotation on UniProt →
Function. Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix.
Subunit / interactions. Component of the cytochrome c oxidase (complex IV, CIV), a multisubunit enzyme composed of 14 subunits. The complex is composed of a catalytic core of 3 subunits MT-CO1, MT-CO2 and MT-CO3, encoded in the mitochondrial DNA, and 11 supernumerary subunits COX4I1 (or COX4I2), COX5A, COX5B, COX6A1 (or COX6A2), COX6B1 (or COX6B2), COX6C, COX7A2 (or COX7A1), COX7B, COX7C, COX8A and COXFA4, which are encoded in the nuclear genome. The complex exists as a monomer or a dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)). Interacts with RAB5IF.
Subcellular location. Mitochondrion inner membrane.
Pathway. Energy metabolism; oxidative phosphorylation.
Similarity. Belongs to the cytochrome c oxidase VIIc family.
RefSeq proteins (1): NP_001858* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004202 | COX7C/Cox8 | Family |
| IPR036636 | COX7C/Cox8_sf | Homologous_superfamily |
Pfam: PF02935
UniProt features (7 total): topological domain 2, modified residue 2, transit peptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9I6F | ELECTRON MICROSCOPY | 2.95 |
| 9I7U | ELECTRON MICROSCOPY | 3.15 |
| 5Z62 | ELECTRON MICROSCOPY | 3.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P15954-F1 | 91.28 | 0.63 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 25, 25
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-5628897 | TP53 Regulates Metabolic Genes |
| R-HSA-611105 | Respiratory electron transport |
| R-HSA-9707564 | Cytoprotection by HMOX1 |
| R-HSA-9864848 | Complex IV assembly |
MSigDB gene sets: 193 (showing top):
MODULE_93, HONMA_DOCETAXEL_RESISTANCE, MODULE_151, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, MORF_UBE2I, MORF_HDAC1, HSIAO_HOUSEKEEPING_GENES, RODWELL_AGING_KIDNEY_NO_BLOOD_DN, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, MORF_SKP1A, GOBP_OXIDATIVE_PHOSPHORYLATION, MORF_CTBP1, GOBP_ELECTRON_TRANSPORT_CHAIN, GNF2_FBL, KEGG_HUNTINGTONS_DISEASE
GO Biological Process (4): generation of precursor metabolites and energy (GO:0006091), mitochondrial electron transport, cytochrome c to oxygen (GO:0006123), cellular respiration (GO:0045333), oxidative phosphorylation (GO:0006119)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), respiratory chain complex IV (GO:0045277), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-4 pathways:
| Category | Pathways |
|---|---|
| Transcriptional Regulation by TP53 | 1 |
| Aerobic respiration and respiratory electron transport | 1 |
| Cellular response to chemical stress | 1 |
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metabolic process | 1 |
| aerobic electron transport chain | 1 |
| mitochondrial ATP synthesis coupled electron transport | 1 |
| energy derivation by oxidation of organic compounds | 1 |
| aerobic respiration | 1 |
| proton motive force-driven ATP synthesis | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cytochrome complex | 1 |
| respiratory chain complex | 1 |
| transmembrane transporter complex | 1 |
| oxidoreductase complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1738 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COX7C | COX6C | P09669 | 987 |
| COX7C | COX5B | P10606 | 983 |
| COX7C | COX7B | P24311 | 948 |
| COX7C | COX6B1 | P14854 | 908 |
| COX7C | COX6A1 | P12074 | 846 |
| COX7C | COX8A | P10176 | 846 |
| COX7C | COX5A | P20674 | 839 |
| COX7C | COX6A2 | Q02221 | 810 |
| COX7C | COXFA4 | O00483 | 798 |
| COX7C | COX7A1 | P24310 | 764 |
| COX7C | NDUFA1 | O15239 | 737 |
| COX7C | MT-ND5 | P03915 | 736 |
| COX7C | NDUFB9 | Q9Y6M9 | 725 |
| COX7C | MT-CO2 | P00403 | 713 |
| COX7C | COA6 | Q5JTJ3 | 704 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COX7C | MAGEA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX7C | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| MT-CO2 | COX6C | psi-mi:“MI:0915”(physical association) | 0.560 |
| COX5B | COX7A2L | psi-mi:“MI:0914”(association) | 0.530 |
| COX7C | E6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| K8.1 | EXOC5 | psi-mi:“MI:0914”(association) | 0.350 |
| NMES1 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA4 | NUDT19 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA4 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA4 | COX7A2L | psi-mi:“MI:0914”(association) | 0.350 |
| rep | STXBP3 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| COX7C | COX7A2L | psi-mi:“MI:0914”(association) | 0.350 |
| CLPP | NDUFA4 | psi-mi:“MI:2364”(proximity) | 0.270 |
| COX7C | MAGEA2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| COX7C | CIDEB | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (108): COX7C (Affinity Capture-MS), COX7C (Affinity Capture-MS), COX7C (Affinity Capture-MS), EIF3C (Positive Genetic), PGK1 (Negative Genetic), SKA3 (Positive Genetic), COX7C (Proximity Label-MS), BCAP31 (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX7C (Co-fractionation), COX5A (Co-fractionation), PHB (Co-fractionation), ATP5F1 (Co-fractionation)
ESM2 similar proteins: C0HLM6, D3Z7Q2, D3ZAF6, E7EXZ6, F1MDB2, O95563, P00130, P00430, P12633, P13182, P13184, P14406, P15954, P17665, P29419, P35171, P56135, P56385, P60025, P61638, P61639, P80432, Q00361, Q01321, Q06185, Q1W0Y2, Q28851, Q2KHV4, Q3B8P0, Q53CF9, Q53CG2, Q5R4Z3, Q5R5H4, Q5RBW2, Q5XIA8, Q5XJY4, Q62425, Q7YRK5, Q8L7H8, Q8N5G0
Diamond homologs: P00430, P15954, P17665, P60025, P61638, P61639, P80334, P80432, Q1W0Y2, Q53CF9, Q53CG2, Q7YRK5, Q8SPI1, Q8SQ80, Q8SQ81
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| YY1 | “up-regulates quantity by expression” | COX7C | “transcriptional regulation” |
| COX7C | “form complex” | “Cytochrome c oxidase-Mitochondrial respiratory chain complex IV” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 18 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Respiratory electron transport | 5 | 43.3× | 2e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
584 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:86619393:C:G | donor_gain | 1.0000 |
| 5:86619443:G:GG | donor_gain | 1.0000 |
| 5:86619471:G:GT | donor_gain | 1.0000 |
| 5:86618051:GCG:G | donor_gain | 0.9900 |
| 5:86619349:ACAG:A | acceptor_loss | 0.9900 |
| 5:86619350:CA:C | acceptor_loss | 0.9900 |
| 5:86619351:A:AG | acceptor_gain | 0.9900 |
| 5:86619351:AG:A | acceptor_loss | 0.9900 |
| 5:86619352:G:GG | acceptor_gain | 0.9900 |
| 5:86619352:G:T | acceptor_loss | 0.9900 |
| 5:86619352:GA:G | acceptor_gain | 0.9900 |
| 5:86619352:GAA:G | acceptor_gain | 0.9900 |
| 5:86619397:GATGT:G | donor_gain | 0.9900 |
| 5:86619440:GTA:G | donor_gain | 0.9900 |
| 5:86619441:T:TA | donor_gain | 0.9900 |
| 5:86619442:A:AA | donor_gain | 0.9900 |
| 5:86619466:A:G | donor_gain | 0.9900 |
| 5:86620662:TTGCA:T | acceptor_loss | 0.9900 |
| 5:86620663:TGCA:T | acceptor_loss | 0.9900 |
| 5:86620664:GCA:G | acceptor_loss | 0.9900 |
| 5:86620665:CAGA:C | acceptor_loss | 0.9900 |
| 5:86620666:A:AG | acceptor_gain | 0.9900 |
| 5:86620666:A:C | acceptor_loss | 0.9900 |
| 5:86620667:G:GG | acceptor_gain | 0.9900 |
| 5:86620667:GAT:G | acceptor_gain | 0.9900 |
| 5:86620667:GATAT:G | acceptor_gain | 0.9900 |
| 5:86618116:G:GT | donor_gain | 0.9800 |
| 5:86619352:GAATT:G | acceptor_gain | 0.9800 |
| 5:86619466:A:AG | donor_gain | 0.9800 |
| 5:86618128:AAG:A | donor_loss | 0.9700 |
AlphaMissense
403 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:86619414:G:A | G46E | 0.991 |
| 5:86619426:C:A | A50D | 0.991 |
| 5:86619413:G:A | G46R | 0.989 |
| 5:86619413:G:C | G46R | 0.989 |
| 5:86619401:T:C | C42R | 0.981 |
| 5:86619420:C:A | A48E | 0.981 |
| 5:86619362:T:C | F29L | 0.980 |
| 5:86619363:T:C | F29S | 0.980 |
| 5:86619364:T:A | F29L | 0.980 |
| 5:86619364:T:G | F29L | 0.980 |
| 5:86619407:T:G | Y44D | 0.980 |
| 5:86619393:C:A | A39D | 0.972 |
| 5:86618087:C:T | T11I | 0.970 |
| 5:86619360:C:A | P28Q | 0.962 |
| 5:86618096:T:A | V14D | 0.960 |
| 5:86619355:T:A | N26K | 0.959 |
| 5:86619355:T:G | N26K | 0.959 |
| 5:86619399:T:G | M41R | 0.958 |
| 5:86619425:G:C | A50P | 0.958 |
| 5:86618126:G:A | G24E | 0.953 |
| 5:86619434:T:C | F53L | 0.953 |
| 5:86619436:C:A | F53L | 0.953 |
| 5:86619436:C:G | F53L | 0.953 |
| 5:86618080:T:C | F9L | 0.948 |
| 5:86618082:C:A | F9L | 0.948 |
| 5:86618082:C:G | F9L | 0.948 |
| 5:86618126:G:T | G24V | 0.948 |
| 5:86619399:T:A | M41K | 0.948 |
| 5:86619429:C:A | T51K | 0.947 |
| 5:86618125:G:T | G24W | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000433990 (5:86618363 C>A,T), RS1000465045 (5:86618621 C>T), RS1000630921 (5:86617281 T>C), RS1000795389 (5:86617435 C>T), RS1001435985 (5:86619810 C>T), RS1002624077 (5:86619709 C>G,T), RS1002870116 (5:86616417 A>G), RS1002901137 (5:86616788 T>C), RS1003772964 (5:86621234 A>G), RS1003868323 (5:86617905 G>C,T), RS1004564099 (5:86620541 C>A), RS1005196971 (5:86618174 T>G), RS10059868 (5:86616740 T>C), RS1006209316 (5:86619012 T>C), RS1006241997 (5:86619268 G>A,C)
Disease associations
OMIM: gene MIM:603774 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002041_5 | Blood trace element (Cu levels) | 2.000000e-06 |
| GCST006618_3 | Uterine fibroid size (maximum dimension) | 8.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005267 | serum copper measurement |
| EFO:0009410 | uterine fibroid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
39 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression | 3 |
| Particulate Matter | decreases expression, increases abundance, affects cotreatment | 3 |
| Acetaminophen | affects cotreatment, decreases expression | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Doxorubicin | affects expression, increases expression | 2 |
| bisphenol F | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | increases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| methylparaben | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ochratoxin A | increases expression | 1 |
| isobutyl alcohol | increases abundance, affects cotreatment, decreases expression | 1 |
| pinosylvin | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| CD 437 | decreases expression | 1 |
| chloropicrin | decreases expression | 1 |
| K 7174 | decreases expression | 1 |
| 3-(4’-hydroxy-3’-adamantylbiphenyl-4-yl)acrylic acid | decreases expression | 1 |
| bisphenol B | increases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Estradiol | decreases expression | 1 |
| Fluorouracil | affects expression | 1 |
| Gasoline | affects cotreatment, decreases expression, increases abundance | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.